TUESDAY, March 29, 2022 (HealthDay News) — Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS). In an analysis of Amylyx Pharmaceuticals’ drug, known for now onlyContinue Reading

MONDAY, March 28, 2022 (HealthDay News) — Special needs children often require out-of-network care from specialists, which means more out-of-pocket costs and extra stress for families, a new study finds. “In the U.S., the reality is that the more health care needs you have, especially from specialists, the greater chanceContinue Reading

FRIDAY, March 25, 2022 (HealthDay News) — The U.S. Food and Drug Administration authorized several tobacco-flavored vaping products made by the company Logic on Thursday, and added that it would soon announce whether other big-name brands can continue to sell their products in this country. The agency said it hasContinue Reading